Combined X-ray, NMR, and Kinetic Analyses Reveal Uncommon Binding Characteristics of the Hepatitis C Virus NS3-NS4A Protease Inhibitor BI 201335
about
Molecular Mechanism by Which a Potent Hepatitis C Virus NS3-NS4A Protease Inhibitor Overcomes Emergence of ResistanceHCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitorsThe discovery and development of boceprevir.In vitro resistance profile of the hepatitis C virus NS3 protease inhibitor BI 201335.Effect of D168V mutation in NS3/4A HCV protease on susceptibilities of faldaprevir and danoprevir.Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 following Treatment with Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies.Protease inhibitor resistance mutations in untreated Brazilian patients infected with HCV: novel insights about targeted genotyping approaches.The presence of resistance mutations to protease and polymerase inhibitors in Hepatitis C virus sequences from the Los Alamos databank.Halogen bonding between anions and iodoperfluoroorganics: solution-phase thermodynamics and multidentate-receptor design.
P2860
Q27675615-C83C743D-3770-48E6-B59E-04C2FF571178Q28481038-332D8037-F662-4300-B8F6-29D7D7D2EA0FQ38147336-86D2E50B-3447-4BBE-9579-FA003814A343Q40327697-956EA83B-1204-48E3-8867-AEBF59E016E3Q40545307-F0665789-0F6A-4A74-B5EE-A09A7BE7FCEFQ40714351-9AF37FB9-57A7-4574-963D-9F8EA95EE201Q42205040-7A89DD19-AB3A-478E-9CDD-2D2C08924AFDQ42991856-C55F95F6-6B38-45C8-86AA-C87C80FB6CDCQ51598902-078145B8-5D24-4599-B257-56AAE4B1711B
P2860
Combined X-ray, NMR, and Kinetic Analyses Reveal Uncommon Binding Characteristics of the Hepatitis C Virus NS3-NS4A Protease Inhibitor BI 201335
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Combined X-ray, NMR, and Kinet ...... A Protease Inhibitor BI 201335
@ast
Combined X-ray, NMR, and Kinet ...... A Protease Inhibitor BI 201335
@en
Combined X-ray, NMR, and Kinet ...... A Protease Inhibitor BI 201335
@nl
type
label
Combined X-ray, NMR, and Kinet ...... A Protease Inhibitor BI 201335
@ast
Combined X-ray, NMR, and Kinet ...... A Protease Inhibitor BI 201335
@en
Combined X-ray, NMR, and Kinet ...... A Protease Inhibitor BI 201335
@nl
prefLabel
Combined X-ray, NMR, and Kinet ...... A Protease Inhibitor BI 201335
@ast
Combined X-ray, NMR, and Kinet ...... A Protease Inhibitor BI 201335
@en
Combined X-ray, NMR, and Kinet ...... A Protease Inhibitor BI 201335
@nl
P2093
P2860
P356
P1476
Combined X-ray, NMR, and Kinet ...... A Protease Inhibitor BI 201335
@en
P2093
Christopher T Lemke
Diane Thibeault
Montse Llinàs-Brunet
Nathalie Goudreau
Oliver Hucke
Peter W White
Songping Zhao
P2860
P304
P356
10.1074/JBC.M110.211417
P407
P577
2011-04-01T00:00:00Z